Clinical Trial

San Raffaele Registry on Liver Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This is a Retrospective and Prospective Observational Single-Center Study. The purpose is to collect all data to generate a registry of primary liver cancer (hepatocellular carcinoma and biliary tract carcinoma) of patients accessing to San Raffaele Hospital. An additional purpose is to identify novel biomarkers to better manage primary liver cancer patients, for whom additional biological samples will be collected. A total of 4000 patients will be enrolled; for the prospective cohort: from protocol approval to the achievement of the last planned patients in the prospective cohort (2000 patients). The retrospective cohort will start from the year 2000. Patients will be followed for 5 years of follow-up.
Trial Details
NCT Number NCT07704489
Lead Sponsor IRCCS San Raffaele
Conditions Liver and Intrahepatic Biliary Tract Cancer
Enrollment 4,000 participants
Start Date 2021-10-20
Primary Completion 2050-10 (estimated)
Study Completion 2050-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-15